Degnan Chris
CIK 0001741968
Chief Financial Officer
Filings
6
Latest Feb 3, 2026
Issuers covered
2
Showing
6 of 6
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +7.3% | +7.3% | +48.7% | -34.1% |
| 90 days | 2 | 50% | +27.3% | +27.3% | +81.0% | -26.3% |
| 180 days | 2 | 0% | -48.6% | -48.6% | -7.4% | -89.7% |
| 365 days | 1 | 0% | -88.5% | -88.5% | -88.5% | -88.5% |
Issuers
Companies where Degnan Chris has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GRTX | Galera Therapeutics, Inc. | 3 | Mar 14, 2023 |
| URGN | Urogen Pharma Ltd. | 3 | Feb 3, 2026 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|